2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Cancer of Intestines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adlercreutz, H; Heinonen, S; Karppinen, S; Mättö, J; Mutanen, M; Oikarinen, S; Poutanen, K | 1 |
| Eklund, PC; Mutanen, M; Oikarinen, SI; Pajari, AM; Sjöholm, RE; Smeds, AI | 1 |
2 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Cancer of Intestines
| Article | Year |
|---|---|
Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.
Topics: 4-Butyrolactone; Animals; Bifidobacterium; Dietary Fiber; Genes, APC; Intestinal Neoplasms; Intestine, Large; Lignans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Animal; Plant Extracts; Random Allocation; Secale | 2003 |
The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation.
Topics: 4-Butyrolactone; Adenomatous Polyposis Coli Protein; Animals; Butylene Glycols; Diet; Disease Models, Animal; Female; Furans; Intestinal Neoplasms; Lignans; Male; Mice; Mice, Inbred C57BL; Plants | 2006 |